◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

ASKA Pharmaceutical Holdings Co.,Ltd.

Loading...
Price History
Market Data
Market Cap62.8B
P/E Ratio13.16
P/B Ratio0.91
EPS179.95
Dividend Yield-
D/E Ratio0.45
Current Ratio2.54
Market SegmentPrime
AccountingJapan GAAP
CurrencyJPY
Business Overview

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Pharmaceutical PHARMACEUTICAL TSE
Key Financial Metrics
64.1B
Revenue
5.1B
Net Income
179.95
EPS (Diluted)
-3.6B
Free Cash Flow
Profitability
Gross Margin -
Operating Margin 8.3%
Net Profit Margin 8.0%
EBITDA 7.6B
Returns & Efficiency
Return on Assets (ROA) 5.1%
Return on Equity (ROE) 7.4%
Dividend Yield -
EPS 179.95
Financial Health
Total Assets 100.5B
Total Debt 31.3B
Debt to Equity 0.45x
Current Ratio 2.54
Company Info
IndustryPHARMACEUTICAL
Market SegmentPrime
AccountingJapan GAAP
CurrencyJPY
Fiscal Year2025
Peers
14.2T
P/E: 32.8
5.7T
P/E: 15.6
5.3T
P/E: 19.4
4.3T
P/E: 34.2
2.9T
P/E: 16.8
1.3T
P/E: 27.2
1.2T
P/E: 18.3
Stock Chart
Open Full Chart View

Full charting with technical indicators, candlestick, line charts, and more.

Company Profile
General Information
Company NameASKA Pharmaceutical Holdings Co.,Ltd.
Ticker4886
ExchangeTSE
SectorPharmaceutical
IndustryPHARMACEUTICAL
Market SegmentPrime
AccountingJapan GAAP
Fiscal Year2025
CurrencyJPY
Financial Summary
Market Cap62.8B
Revenue64.1B
Net Income5.1B
P/E Ratio13.16
EPS179.95
Net Margin8.0%
ROE7.4%
Dividend Yield-
Description

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...